The silencing of RUNX3 by hemizygous deletion or DNA hypermethylation and the resultant reduced expression of RUNX3 protein is common in many types of cancers, including bile duct, lung, and pancreatic cancers (Wada et al. 2004; Yanada et al. 2005). Here, RUNX3 is linked to pancreatic neoplasm.